BENJAMIN EDWARDS INC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
BENJAMIN EDWARDS INC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20.0%1,5370.0%0.00%
Q2 2023$2
-33.3%
1,537
-11.0%
0.00%
-100.0%
Q1 2023$3
-40.0%
1,726
-16.7%
0.00%0.0%
Q4 2022$5
-99.9%
2,0730.0%0.00%
-66.7%
Q3 2022$9,000
+50.0%
2,0730.0%0.00%
+50.0%
Q2 2022$6,000
-33.3%
2,073
+38.7%
0.00%
-33.3%
Q1 2022$9,000
+350.0%
1,495
+520.3%
0.00%
+200.0%
Q4 2021$2,0002410.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders